Showing results (2351-2360 of 5,538) with videos related to
Sort By:
Pageof 554
Theranostics|March 15, 2019
Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCNQitong Zhang, Qingquan Zhang, Xue Jiang, et al.Theranostics|March 15, 2019
Design strategies and application progress of therapeutic exosomesChunying Liu, Changqing SuTheranostics|March 15, 2019
GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancerHui Huang, Yang Dong, Yanhua Zhang, et al.Theranostics|March 15, 2019
Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagyXiaofei Zhang, Zihao Qi, Huijing Yin, et al.Theranostics|March 15, 2019
Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis BZeyu Sun, Xiaoli Liu, Daxian Wu, et al.Theranostics|March 15, 2019
Quantification of human neuromuscular function through optogeneticsOlaia F Vila, Sebastien G M Uzel, Stephen P Ma, et al.Theranostics|March 15, 2019
A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic CancerAndreas W Berger, Daniel Schwerdel, Anke Reinacher-Schick, et al.Theranostics|March 15, 2019
Iron Oxide Nanoflowers @ CuS Hybrids for Cancer Tri-Therapy: Interplay of Photothermal Therapy, Magnetic Hyperthermia and Photodynamic TherapyAlberto Curcio, Amanda K A Silva, Sonia Cabana, et al.Theranostics|March 15, 2019
Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent ModelsQilong Wang, Ping Zhang, Zhongmin Li, et al.Theranostics|April 25, 2017
The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancerDe-Wei Wu, Po-Lin Lin, Lee Wang, et al.Pageof 554